Cargando…

OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study

OBJECTIVE: To compare the frequency of respiratory tract infections in children treated with OM-85 BV and placebo during the 3-month therapy period, and observation for a further 3 months after treatment. METHODS: A randomized, double-blind, placebo-controlled trial was conducted with 54 children (6...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Fátima Cleonice, Mocellin, Magáli, Ongaratto, Renata, Leitão, Lidiane Alves de Azeredo, Friedrich, Frederico Orlando, Silveira, Victória d’A, Scotta, Marcelo Comerlato, Pitrez, Paulo Márcio, Pinto, Leonardo Araújo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032885/ https://www.ncbi.nlm.nih.gov/pubmed/32130328 http://dx.doi.org/10.31744/einstein_journal/2020AO5262

Ejemplares similares

Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study
por: Gao, Jinming, et al.
Publicado: (2021)

OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance
por: TROIANO, GIANMARCO, et al.
Publicado: (2021)

Association between interleukin-10 polymorphisms and CD4(+)CD25(+)FOXP3(+) T cells in asthmatic children
por: Mocellin, Magáli, et al.
Publicado: (2021)

Azithromycin administered for acute bronchiolitis may have a protective effect on subsequent wheezing
por: Luisi, Fernanda, et al.
Publicado: (2020)

OM-85 is an immunomodulator of interferon-β production and inflammasome activity
por: Dang, A. T., et al.
Publicado: (2017)

Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response
por: Baladi, S., et al.
Publicado: (1994)

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
por: Antunes, Krist Helen, et al.
Publicado: (2022)

Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers
por: Berber, Arturo, et al.
Publicado: (2019)

Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study
por: Bodemer, Christine, et al.
Publicado: (2017)

Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art
por: De Benedetto, Fernando, et al.
Publicado: (2013)

Impact of maternal dTpa vaccination on the incidence of pertussis in young infants
por: Friedrich, Frederico, et al.
Publicado: (2020)

Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

The OM-85 bacterial lysate: a new tool against SARS-CoV-2?
por: Pivniouk, Vadim, et al.
Publicado: (2023)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

IRF7-Associated Immunophenotypes Have Dichotomous Responses to Virus/Allergen Coexposure and OM-85-Induced Reprogramming
por: de Jong, Emma, et al.
Publicado: (2021)

Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85
por: Esposito, Susanna, et al.
Publicado: (2022)

Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
por: Ballarini, Stefania, et al.
Publicado: (2022)

Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway
por: Parola, Carmen, et al.
Publicado: (2013)

Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
por: Koatz, Ana M., et al.
Publicado: (2016)

A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections
por: Esposito, Susanna, et al.
Publicado: (2019)

Lack of association between viral load and severity of acute bronchiolitis in infants
por: de Souza, Ana Paula Duarte, et al.
Publicado: (2016)

To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial
por: Gao, Jinming, et al.
Publicado: (2014)

Respiratory viral coinfection and disease severity in children: A systematic review and meta-analysis
por: Scotta, Marcelo Comerlato, et al.
Publicado: (2016)

Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM‐85
por: Lauzon‐Joset, Jean‐Francois, et al.
Publicado: (2021)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

Identifying Organic Matter (OM) Types and Characterizing OM Pores in the Wufeng–Longmaxi Shales
por: Xie, Guoliang, et al.
Publicado: (2022)

Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice
por: Rossi, Giovanni A., et al.
Publicado: (2018)

Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study
por: Esposito, Susanna, et al.
Publicado: (2019)

OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
por: Fang, Lei, et al.
Publicado: (2021)

Clinical characteristics and predictors of mechanical ventilation in patients with COVID-19 hospitalized in Southern Brazil
por: Bastos, Gisele Alsina Nader, et al.
Publicado: (2020)

Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP
por: Roth, Michael, et al.
Publicado: (2017)

Professor Om Prakash Sharma
por: Shrivastava, Nirbhay
Publicado: (2011)

Réunion de l'OMS
por: World Health Organization. Copenhagen. Regional Office for Europe
Publicado: (1986)

Florence Nightingale, O.M.
Publicado: (1910)

Motivatie om te bewegen
por: Rombout, Betty
Publicado: (2020)

The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites
por: Cheudjeu, Antony
Publicado: (2022)

Kapløb om at hitte det allermindste
por: Bruun, T
Publicado: (1983)

Det handler om livets gåde
por: Stokholm, P
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_87tobtbrab33iqe77vlm8b1bc2